Vanda Pharmaceuticals reported $461.81M in Current Assets for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Acadia Pharmaceuticals ACAD:US $ 640.92M 4.81M
Agios Pharmaceuticals AGIO:US $ 1305.29M 397.28M
Akebia Therapeutics AKBA:US $ 330.08M 0.99M
Alnylam Pharmaceuticals ALNY:US $ 2675.36M 49.8M
Anika Therapeutics ANIK:US $ 165.78M 11.98M
Arena Pharmaceuticals ARNA:US $ 790.92M 199.52M
Arrowhead Research ARWR:US $ 384.6M 141.36M
AstraZeneca AZN:LN 26.69B 583M
Bluebird Bio BLUE:US $ 832.32M 71.2M
Bristol Myers Squibb BMY:US $ 31443M 2282M
Clovis Oncology CLVS:US $ 230.67M 65.69M
Eli Lilly And LLY:US $ 17808.3M 512.8M
Enanta Pharmaceuticals ENTA:US $ 319.02M 2.13M
Esperion Therapeutics ESPR:US $ 170.67M 104.51M
Halozyme Therapeutics HALO:US $ 1017.3M 17.55M
Heron Therapeutics HRTX:US $ 315.05M 51.77M
Insmed INSM:US $ 958.98M 79.21M
Ligand Pharmaceuticals LGND:US $ 432.08M 21.18M
Minerva Neurosciences NERV:US $ 67.44M 7.79M
Moderna Inc MRNA:US 13.42B 2.46B
Novartis NVS:US $ 26253M 2445M
Ptc Therapeutics PTCT:US $ 1011.14M 55.09M
Puma Biotechnology PBYI:US $ 136.92M 30.83M
Sangamo Biosciences SGMO:US $ 447.4M 106.67M
Takeda 4502:JP Y 2456353M 20105M
Teva Pharmaceutical TEVA:IT 12.15B 668M
Ultragenyx Pharmaceutical RARE:US $ 846.88M 102.61M
Vanda Pharmaceuticals VNDA:US $ 461.81M 15.16M
Veracyte VCYT:US $ 229.31M 142.04M